Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

Ā© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Oncology
intermediate
X-Type

Giant Cell Tumor of Bone

Bone Tumors

A 32-year-old woman presents with 4 months of progressive knee pain and swelling. Radiographs show an eccentric, lytic, expansile lesion in the distal femoral epiphysis extending to the subchondral bone without matrix calcification. There is no periosteal reaction. MRI shows a well-defined lesion with lobular low-to-intermediate T1 and heterogeneous T2 signal. Regarding giant cell tumor (GCT) of bone:

Mark each as TRUE or FALSE

A

GCT is a benign but locally aggressive tumor occurring in skeletally mature patients (peak 20-40 yea...

B

Radiographic features include eccentric, lytic, expansile lesion in the epiphysis with well-defined ...

C

GCT is a malignant tumor occurring in children; it arises in the metaphysis with sclerotic margins; ...

D

Histology shows multinucleated osteoclast-like giant cells (RANK-expressing) admixed with mononuclea...

E

Denosumab (RANKL inhibitor) is used for unresectable, recurrent, or metastatic GCT; it reduces tumor...

Answer the questions to see explanations

Click T (True) or F (False) for each option